Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
102,398,919
-
Number of holders
-
6
-
Total 13F shares, excl. options
-
9,086
-
Shares change
-
-20,910
-
Total reported value, excl. options
-
$48,891
-
Value change
-
-$103,371
-
Number of buys
-
3
-
Number of sells
-
3
-
Price
-
$5.42
Institutional Holders of Pasithea Therapeutics Corp. - Common Stock (KTTA) as of Q3 2024
As of 30 Sep 2024 Pasithea Therapeutics Corp. - Common Stock (KTTA) had 8 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 9,086 shares of stock of the company.
Largest 8 holders included UBS Group AG, MORGAN STANLEY, Tower Research Capital LLC (TRC), Royal Bank of Canada, JPMORGAN CHASE & CO, BANK OF AMERICA CORP /DE/, FMR LLC, and ADAR1 Capital Management, LLC.
This table shows 8 institutional shareholders of the security as of 30 Sep 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.